Issue 27, 2025

Combating multiple aetiologies of Alzheimer's disease to rescue behavioural deficits

Abstract

Alzheimer's disease (AD) encompasses a range of intricate pathologies characterized by aberrant protein aggregation, atypical accumulation of metal ions, increased levels of reactive oxygen species (ROS), oxidative stress, neuroinflammation, and synaptic dysfunction. These collectively contribute to a decline in learning, memory, and cognitive abilities, broadly classified as dementia. AD accounting for most of the dementia cases remains a significant health challenge. Despite extensive research, therapeutic advancements for AD and other neurodegenerative diseases (NDDs) have achieved modest success. In this context, our study presents a hybrid drug design approach involving strategic and tactical repurposing of the structural and functional pharmacophores of current or failed drugs and biologically active compounds by integrating them into a single structural framework to concurrently target key pathological hallmarks viz., amyloid beta (Aβ), tau, metal ions, ROS, and neuroinflammation (NLRP3 inflammasome). The evaluation of in vitro and cellular models of Aβ, tau, and microglia highlights the efficacy of the fluoro-derivative DM4 in mitigating multiple etiological factors. DM4 exhibits excellent blood–brain barrier (BBB) permeability and biocompatibility. DM4 effectively reduced the amyloid burden, neuroinflammation, synaptic dysfunction, and neurodegeneration in the APP/PSEN1 transgenic AD mouse model. Behavioural assessments corroborated the rescue of learning and memory deficits, thereby presenting a viable strategy for the treatment of neurodegeneration and its associated cognitive decline.

Graphical abstract: Combating multiple aetiologies of Alzheimer's disease to rescue behavioural deficits

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Edge Article
Submitted
19 Tsh 2024
Accepted
28 Mot 2025
First published
06 Jan 2025
This article is Open Access

All publication charges for this article have been paid for by the Royal Society of Chemistry
Creative Commons BY-NC license

Chem. Sci., 2025,16, 12476-12492

Combating multiple aetiologies of Alzheimer's disease to rescue behavioural deficits

M. Ramesh, C. Balachandra, A. Kumar, S. Samanta and T. Govindaraju, Chem. Sci., 2025, 16, 12476 DOI: 10.1039/D4SC08585J

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements